A Randomized Phase II Trial Comparing Cetuximab With Concurrent Pemetrexed/Cetuximab Therapy for Non-Small Cell Lung Cancer Refractory to Primary Treatment.
Phase of Trial: Phase II
Latest Information Update: 28 May 2014
At a glance
- Drugs Cetuximab (Primary) ; Pemetrexed
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 28 Mar 2014 Status changed from completed to discontinued as reported by ClinicalTrials.gov record.
- 14 Jun 2011 Planned end date changed from 1 Jul 2011 to 1 Jul 2013 as reported by ClinicalTrials.gov.
- 15 Oct 2010 Planned end date changed from Jul 2008 to Jul 2011 as reported by ClinicalTrials.gov.